Revonto (dantroene sodium injection)

Revonto (dantrolene sodium for injection) is a skeletal muscle relaxant indicated, along with appropriate supportive measures, for the management of fulminant hypermetabolism of skeletal muscle characteristic of malignant hyperthermia crises in patients of all ages. Revonto is also indicated preoperatively and sometimes postoperatively, to prevent or attenuate the development of clinical and laboratory signs of malignant hyperthermia in individuals judged to be malignant hyperthermia susceptible.

Ryanodex (dantrolene sodium injectable suspension)

Ryanodex (dantrolene sodium) is a skeletal muscle relaxant used to treat malignant hyperthermia in conjunction with appropriate supportive measures, and to prevent malignant hyperthermia in patients at high risk.

Danyelza (naxitamab-gqgk injection)

Danyelza (naxitamab-gqgk) is a GD2-binding monoclonal antibody indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), to treat pediatric patients 1 year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy.

Xigduo XR (dapagliflozin and metformin hcl extended-release tablets)

Xigduo XR (dapagliflozin and metformin HCl) is a combination of two oral antihyperglycemic medications used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate.

Qtern (dapagliflozin and saxagliptin tablets, for oral use)

Qtern (dapagliflozin and saxagliptin) tablets are a sodium-glucose cotransporter 2 (SGLT-2) inhibitor and a dipeptidyl peptidase-4 (DPP-4) inhibitor combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM) who have inadequate control with dapagliflozin or who are already treated with dapagliflozin and saxagliptin.

Farxiga (dapagliflozin film-coated tablets)

Farxiga (dapagliflozin) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Qternmet XR (dapagliflozin, saxagliptin, and metformin hydrochloride)

Qternmet XR (dapagliflozin, saxagliptin, and metformin hydrochloride) is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and a biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. 

Jesduvroq (daprodustat tablets)

Jesduvroq (daprodustat) is a hypoxia-inducible factor prolyl hydroxylase (HIF PH) inhibitor indicated for the treatment of anemia due to chronic kidney disease in adults who have been receiving dialysis for at least four months.

Dapsone (dapsone)

Daptacel (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed)

Daptacel [(diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP)] is an immunization used to help prevent the diseases of diphtheria, tetanus, and pertussis. Most children who are vaccinated with DTaP will be protected throughout childhood. Daptacel is available in generic form.